Irimura T, Ota D M, Cleary K R
Cancer Res. 1987 Feb 1;47(3):881-9.
A Ulex europeus agglutinin I (UEAI)-reactive glycoprotein(s) with molecular weight higher than 300,000 was detected by direct binding of 125I-labeled UEAI to lysates of rectal or sigmoid colon cancer tissues separated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. This was the major UEAI-reactive molecule in tumor tissues and different tumors possessed varying reactivities. Very little UEAI binding was detected to lower molecular weight components. Histochemical localization of UEAI confirmed that the UEAI-reactive molecules were mostly localized to the surface of carcinoma cells. A total of 135 fresh tissue samples, including those from adenocarcinoma, villous adenoma, and normal mucosa in surgical specimens (69 patients), were examined to determine the reactivities of UEAI to the high molecular weight component in the tissue extracts. The quantitative binding of 125I-UEAI was compared according to the stage of colorectal cancer at the time of surgery. The relative amount of UEAI-reactive high molecular weight substance was significantly higher in the carcinomas than in normal mucosa. UEAI binding to high molecular weight regions of the polyacrylamide gel was significantly lower in primary colorectal adenocarcinomas from stage C or D patients than in those from stage B1 patients. Therefore, increased expression of the UEAI-reactive molecule was related to transformation of colorectal epithelial cells and decreased expression appeared to be associated with progression and metastatic potential.
在十二烷基硫酸钠存在的情况下,通过聚丙烯酰胺凝胶电泳分离直肠或乙状结肠癌组织裂解物,然后将¹²⁵I标记的欧洲荆豆凝集素I(UEAI)直接与其结合,检测到一种分子量高于300,000的UEAI反应性糖蛋白。这是肿瘤组织中主要的UEAI反应性分子,不同肿瘤具有不同的反应性。未检测到UEAI与低分子量成分的明显结合。UEAI的组织化学定位证实,UEAI反应性分子大多定位于癌细胞表面。共检测了135份新鲜组织样本,包括手术标本(69例患者)中的腺癌、绒毛状腺瘤和正常黏膜样本,以确定UEAI对组织提取物中高分子量成分的反应性。根据手术时结直肠癌的分期比较了¹²⁵I-UEAI的定量结合情况。癌组织中UEAI反应性高分子量物质的相对含量显著高于正常黏膜。C期或D期患者原发性结直肠癌中UEAI与聚丙烯酰胺凝胶高分子量区域的结合明显低于B1期患者。因此,UEAI反应性分子表达的增加与结直肠上皮细胞的转化有关,而表达的降低似乎与进展和转移潜能有关。